Analysis and Insights
Technical Analysis:
MKS Instruments Inc. (MKSI) is currently trading at $82.76 as of the latest update on 2025-03-10. The stock has entered oversold territory with an RSI of 26.82, suggesting potential buying opportunities. The Fibonacci pivot point is at $91.31, with resistance levels at $100.15 and $105.61, and support levels at $82.47 and $77.01.
News and Sentiment Analysis:
- Oversold Territory: MKSI has entered oversold territory with an RSI of 26.82, indicating potential buying opportunities.
- Dividend Yield: The company offers a dividend yield of 0.96%, making it attractive for income investors.
- Analyst Ratings: KeyBanc maintains a Buy rating with a price target of $160.00, while the average analyst price target is $133.00, indicating a Strong Buy consensus.
- Insider Activity: Recent insider activity shows negative sentiment, with 29 insiders selling shares, including a significant sale by Director Gerard Colella.
Fundamental Analysis:
- Revenue and Earnings: MKSI reported strong Q4 2024 results with revenue of $935 million and GAAP net income of $90 million, reflecting robust demand across semiconductor, electronics, and industrial sectors.
- Market Growth: The global scientific instruments market is projected to grow at a CAGR of 4.50% from 2025 to 2034, driven by investments in healthcare, biotechnology, and pharmaceuticals.
Conclusion:
Based on the oversold condition, positive analyst sentiment, and strong fundamentals, MKSI is expected to rebound. The stock is likely to test the Fibonacci pivot point of $91.31 in the next trading week.
Predicted Price: $91.31
Recommendation: Buy
Analysis and Insights
Technical Analysis:
MKS Instruments Inc. (MKSI) is currently trading at $82.76 as of the latest update on 2025-03-10. The stock has entered oversold territory with an RSI of 26.82, suggesting potential buying opportunities. The Fibonacci pivot point is at $91.31, with resistance levels at $100.15 and $105.61, and support levels at $82.47 and $77.01.
News and Sentiment Analysis:
- Oversold Territory: MKSI has entered oversold territory with an RSI of 26.82, indicating potential buying opportunities.
- Dividend Yield: The company offers a dividend yield of 0.96%, making it attractive for income investors.
- Analyst Ratings: KeyBanc maintains a Buy rating with a price target of $160.00, while the average analyst price target is $133.00, indicating a Strong Buy consensus.
- Insider Activity: Recent insider activity shows negative sentiment, with 29 insiders selling shares, including a significant sale by Director Gerard Colella.
Fundamental Analysis:
- Revenue and Earnings: MKSI reported strong Q4 2024 results with revenue of $935 million and GAAP net income of $90 million, reflecting robust demand across semiconductor, electronics, and industrial sectors.
- Market Growth: The global scientific instruments market is projected to grow at a CAGR of 4.50% from 2025 to 2034, driven by investments in healthcare, biotechnology, and pharmaceuticals.
Conclusion:
Based on the oversold condition, positive analyst sentiment, and strong fundamentals, MKSI is expected to rebound. The stock is likely to test the Fibonacci pivot point of $91.31 in the next trading week.
Predicted Price: $91.31
Recommendation: Buy